Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis (TB), imposes a significantly high morbidity threat to humans in both developed and developing nations. The …
S Sundararajan, K Karunakaran… - Journal of Biomolecular …, 2023 - Taylor & Francis
The highly flexible nature of Mycobacterium tuberculosis (Mtb) can be owed to its tough cell wall and multiple gene interaction system which makes it resistant to frontline TB drugs …
Rv2984 is one of the polyphosphate kinases present in Mycobacterium tuberculosis involved in the catalytic synthesis of inorganic polyphosphate, which plays an essential role …
M Khan, S Khan, FL Alshammary, S Zaidi… - Journal of …, 2024 - Taylor & Francis
A major obstacle in the treatment of tuberculosis (TB) is to combat the emerging resistant strains of its causing agent ie Mycobacterium tuberculosis (MTb). The emergence of …
Tuberculosis (TB) is a leading cause of mortality amongst infectious diseases. While the anti- TB drugs can cure TB, the non-compliance and rapidly increasing resistance is of serious …
Discovery of new anti-tuberculosis drugs with novel mode of action is urgently needed. The tryptophan synthase is a genetically validated enzyme that catalyzes last step of tryptophan …
Multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis has emerged as global health threat, causing millions of deaths worldwide. Identification of new drug …
SP Swain, S Ahamad, N Samarth, S Singh… - Journal of …, 2023 - Taylor & Francis
Antibiotic resistance against Mycobacterium tuberculosis (M. tb.) has been a significant cause of death worldwide. The Enhanced intracellular survival (EIS) protein of the bacteria is …
Q Zhang, J Han, Y Zhu, S Tan, H Liu - International Journal of Molecular …, 2022 - mdpi.com
Given the current epidemic of multidrug-resistant tuberculosis, there is an urgent need to develop new drugs to combat drug-resistant tuberculosis. Direct inhibitors of the InhA target …